Compare FDMT & DNUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FDMT | DNUT |
|---|---|---|
| Founded | 2013 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Food Chains |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 515.6M | 585.5M |
| IPO Year | 2019 | 2021 |
| Metric | FDMT | DNUT |
|---|---|---|
| Price | $9.64 | $3.32 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 6 |
| Target Price | ★ $31.71 | $4.72 |
| AVG Volume (30 Days) | 755.3K | ★ 1.7M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.06% |
| EPS Growth | ★ 18.79 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $85,209,000.00 | ★ $1,522,616,000.00 |
| Revenue This Year | N/A | $0.55 |
| Revenue Next Year | $70.28 | $3.59 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 230194.60 | N/A |
| 52 Week Low | $2.89 | $2.58 |
| 52 Week High | $12.34 | $5.73 |
| Indicator | FDMT | DNUT |
|---|---|---|
| Relative Strength Index (RSI) | 52.29 | 47.00 |
| Support Level | $8.41 | $3.17 |
| Resistance Level | $10.19 | $3.50 |
| Average True Range (ATR) | 0.69 | 0.15 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 49.59 | 36.34 |
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).
Krispy Kreme Inc is a sweet-treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations world-wide. It derives maximum revenue from the U.S. segment.